{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:39:31Z","timestamp":1763019571405,"version":"3.45.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.idnow.2024.104860","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T21:02:32Z","timestamp":1706821352000},"page":"104860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the predictive value of plasma calprotectin in the evolution of SARS-Cov-2 primo-infection"],"prefix":"10.1016","volume":"54","author":[{"given":"Gauthier","family":"Lignier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Camar\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4437-3448","authenticated-orcid":false,"given":"Thibaut","family":"Jamme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Sophie","family":"Combis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Tayac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Maupas-Schwalm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2024.104860_b0005","unstructured":"Juniorcaius M. Novel Coronavirus(2019-nCoV) Situation Report - 1WHO; 2020. Accessed on 24 August 2022 at https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports."},{"issue":"5","key":"10.1016\/j.idnow.2024.104860_b0010","first-page":"97","article-title":"Using Early Data to Estimate the Actual Infection Fatality Ratio from COVID-19 in France","volume":"9","author":"Roques","year":"2020","journal-title":"Biology (Basel)"},{"issue":"1","key":"10.1016\/j.idnow.2024.104860_b0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jiph.2022.11.024","article-title":"Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies","volume":"16","author":"Dhama","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.idnow.2024.104860_b0020","article-title":"Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people","volume":"8","author":"Semenzato","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"10","key":"10.1016\/j.idnow.2024.104860_b0025","doi-asserted-by":"crossref","first-page":"e0241265","DOI":"10.1371\/journal.pone.0241265","article-title":"Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis","volume":"15","author":"Javanmardi","year":"2020","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.idnow.2024.104860_b0030","doi-asserted-by":"crossref","first-page":"e0241955","DOI":"10.1371\/journal.pone.0241955","article-title":"Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review","volume":"15","author":"Izcovich","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.idnow.2024.104860_b0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan","volume":"77","author":"Mao","year":"2020","journal-title":"China JAMA Neurol"},{"key":"10.1016\/j.idnow.2024.104860_b0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40364-020-00217-0","article-title":"A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)","volume":"8","author":"Danwang","year":"2020","journal-title":"Biomark Res"},{"issue":"10223","key":"10.1016\/j.idnow.2024.104860_b0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China Lancet"},{"issue":"7","key":"10.1016\/j.idnow.2024.104860_b0050","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan","volume":"5","author":"Shi","year":"2020","journal-title":"China JAMA Cardiol"},{"key":"10.1016\/j.idnow.2024.104860_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.idnow.2024.104860_b0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12941-021-00420-3","article-title":"The laboratory findings and different COVID-19 severities: a systematic review and meta-analysis","volume":"20","author":"Kazemi","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"3","key":"10.1016\/j.idnow.2024.104860_b0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiol.2020200370","article-title":"Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)","volume":"295","author":"Pan","year":"2020","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.idnow.2024.104860_b0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/etm.2015.2467","article-title":"Treatment and prognosis of COVID-19: Current scenario and prospects (Review)","volume":"21","author":"Li","year":"2021","journal-title":"Exp Ther Med"},{"issue":"6","key":"10.1016\/j.idnow.2024.104860_b0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/RLI.0000000000000672","article-title":"The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia","volume":"55","author":"Li","year":"2020","journal-title":"Invest Radiol"},{"issue":"9","key":"10.1016\/j.idnow.2024.104860_b0080","doi-asserted-by":"crossref","first-page":"e21798","DOI":"10.1096\/fj.202101013","article-title":"S100A8 may govern hyper-inflammation in severe COVID-19","volume":"35","author":"Deguchi","year":"2021","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.idnow.2024.104860_b0085","doi-asserted-by":"crossref","first-page":"e00779","DOI":"10.1128\/IAI.00779-17","article-title":"Role of Calprotectin in Withholding Zinc and Copper from Candida albicans","volume":"86","author":"Besold","year":"2018","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.idnow.2024.104860_b0090","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","article-title":"Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19","volume":"182","author":"Silvin","year":"2020","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.idnow.2024.104860_b0095","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1002\/jmv.28056","article-title":"Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study","volume":"94","author":"Infantino","year":"2022","journal-title":"J Med Virol"},{"issue":"24","key":"10.1016\/j.idnow.2024.104860_b0100","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study","volume":"270","author":"Le Gall","year":"1993","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.idnow.2024.104860_b0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idnow.2024.104860_b0110","doi-asserted-by":"crossref","DOI":"10.21037\/jeccm-20-92","article-title":"Severity of illness scores at presentation predict ICU admission and mortality in COVID-19","volume":"5","author":"Wilfong","year":"2021","journal-title":"J Emerg Crit Care Med"},{"issue":"163","key":"10.1016\/j.idnow.2024.104860_b0115","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0185-2021","article-title":"Post-acute COVID-19 syndrome","volume":"31","author":"Montani","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.idnow.2024.104860_b0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13054-020-02911-9","article-title":"Acute respiratory failure in COVID-19: is it \u201ctypical\u201d ARDS?","volume":"24","author":"Li","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.idnow.2024.104860_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113454","article-title":"Early reduction of estimated Glomerular Filtration Rate (eGFR) predicts poor outcome in acutely ill hospitalized COVID-19 patients firstly admitted to medical regular wards (eGFR-COV19 study)","volume":"153","author":"Cei","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.idnow.2024.104860_b0130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ijid.2021.03.008","article-title":"Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19","volume":"105","author":"Wungu","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.idnow.2024.104860_b0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jinf.2021.01.022","article-title":"COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients","volume":"82","author":"Belsky","year":"2021","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.idnow.2024.104860_b0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.dsx.2020.04.044","article-title":"Is diabetes mellitus associated with mortality and severity of COVID-19?","volume":"14","author":"Kumar","year":"2020","journal-title":"A meta-analysis Diabetes Metab Syndr"},{"issue":"2","key":"10.1016\/j.idnow.2024.104860_b0145","doi-asserted-by":"crossref","first-page":"e3377","DOI":"10.1002\/dmrr.3377","article-title":"Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19)","volume":"37","author":"Zhou","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"10.1016\/j.idnow.2024.104860_b0150","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/1535370216681551","article-title":"Calprotectin in rheumatic diseases","volume":"242","author":"Ometto","year":"2017","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"10.1016\/j.idnow.2024.104860_b0155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/cells11020236","article-title":"S100A8\/A9 Is a Marker for the Release of Neutrophil Extracellular Traps and Induces Neutrophil Activation","volume":"11","author":"Sprenkeler","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.idnow.2024.104860_b0160","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1373\/jalm.2017.024778","article-title":"Sample Type and Storage Conditions Affect Calprotectin Measurements in Blood","volume":"2","author":"Pedersen","year":"2018","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.idnow.2024.104860_b0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cca.2021.02.022","article-title":"Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample type","volume":"517","author":"Mylemans","year":"2021","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.idnow.2024.104860_b0170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cca.2021.12.011","article-title":"Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types","volume":"525","author":"Nevejan","year":"2022","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.idnow.2024.104860_b0175","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jmb.2007.04.065","article-title":"The crystal structure of the human (S100A8\/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins","volume":"370","author":"Korndorfer","year":"2007","journal-title":"J Mol Biol"},{"issue":"50","key":"10.1016\/j.idnow.2024.104860_b0180","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1021\/jacs.8b06354","article-title":"Oxidative Post-translational Modifications Accelerate Proteolytic Degradation of Calprotectin","volume":"140","author":"Stephan","year":"2018","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.idnow.2024.104860_b0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00011-021-01516-4","article-title":"Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study)","volume":"71","author":"Garcia de Guadiana-Romualdo","year":"2022","journal-title":"Inflamm Res"},{"issue":"6","key":"10.1016\/j.idnow.2024.104860_b0190","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.idnow.2024.104860_b0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/17534259211069635","article-title":"Early kinetics of calprotectin in plasma following inguinal hernia surgery","volume":"28","author":"Sejersen","year":"2022","journal-title":"Innate Immun"},{"issue":"7","key":"10.1016\/j.idnow.2024.104860_b0200","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.4103\/jfmpc.jfmpc_545_22","article-title":"Role of cystatin C and calprotectin as potential early prognostic biomarkers in COVID-19 patients admitted to a dedicated COVID care facility","volume":"11","author":"Kumar","year":"2022","journal-title":"J Family Med Prim Care"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:33:55Z","timestamp":1763019235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991924000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2666991924000150"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104860","relation":{},"ISSN":["2666-9919"],"issn-type":[{"type":"print","value":"2666-9919"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the predictive value of plasma calprotectin in the evolution of SARS-Cov-2 primo-infection","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104860"}}